Innova Captab Limited · NSE:INNOVACAP

Innova Captab — FY2026 Earnings Presentation

29 slides from Innova Captab's earnings presentation, May 7, 2026

  1. Slide 1: Intimation of Investor Presentation to Stock Exchanges

    INNOVA CAPTAB LIMITED Plot No. 320, Industrial Area, Phase-1, Panchkula, Pin-134113, Haryana, India. Phone: +91-172-4194500 07th May, 2026 To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Mumbai – 400001 Bandra Kurla

  2. Slide 2: Excelling with Passion, Powering Potential - Investor Presentation May 2026

    Excelling with Passion Powering Potential Investor Presentation - May 2026

  3. Slide 3: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Innova Captab Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securit

  4. Slide 4: Company Overview

    Company Overview

  5. Slide 5: Leading Pharmaceutical Player with Comprehensive Business Model

    Leading Pharmaceutical Player with Comprehensive Business Model Robust Financials Preferred CDMO partner for prominent pharmaceutical companies worldwide, with a strong direct (FY26) presence across geographies through our branded generics business Revenues ₹ 1,630 Cr EBITDA 350 + Presence across 60

  6. Slide 6: Journey of Achieving Major Milestones

    Journey of Achieving Major Milestones Acquisition of Sharon • Innova Captab began its • Received GMP Certificate for • Acquisition of Sharon, through the journey in 2006 with the cephalosporin products from • Further expanded the G block Corporate Insolvency Resolution Process establishment of first

  7. Slide 7: With State-of-the-Art Manufacturing Facilities

    With State-of-the-Art Manufacturing Facilities Key Accreditations 9 Manufacturing Blocks Kathua, Jammu [4 Blocks] 3 Baddi |1 Dehradun |1 Taloja | 4 Jammu Upcoming R&D Baddi, Himachal Pradesh (2 Units) [3 Blocks] Facility in R&D Facility in Baddi, Himachal Pradesh Panchkula, Haryana Dehradun, Uttarak

  8. Slide 8: Q4 & FY26 Performance Highlights

    Q4 & FY26 Performance Highlights

  9. Slide 9: MD's Commentary

    MD’s Commentary Innova Captab Ltd. has a strong performance with YoY revenue growth of 42% in Q4 FY26 and has delivered its highest-ever annual revenue with a growth of 31% in FY26. This strong performance underscores disciplined execution across our operations. This milestone performance was driven

  10. Slide 10: Q4 & FY26 Performance Highlights - Revenue

    Q4 & FY26 Performance Highlights - Revenue Revenue (₹ Crore) +31% 1,630.0 • Revenue from Operations registered strong YoY growth of 42% in Q4 and 31% in FY26 1,243.7 • This performance was driven by strong momentum across both business areas. +42% • Exports contributed 28% to the overall revenue mix

  11. Slide 11: Q4 & FY26 Performance Highlights - Profitability

    Q4 & FY26 Performance Highlights - Profitability EBITDA (₹ crore) Margin 16.2% 14.9% 15.9% 15.4% +26% 250.3 198.2 • EBITDA for Q4 FY26 stood at ₹ 66.7 crores reflecting a robust YoY growth of 31%. For FY26, EBITDA was ₹ 250.3 crores, up 26% YoY. +31% 66.7 51.1 • EBITDA margin came in at 14.9% in Q4

  12. Slide 12: Consolidated Profit & Loss Statement

    Consolidated Profit & Loss Statement Profit and Loss (₹ crore) Q4 FY26 Q4 FY25 YoY Growth FY26 FY25 YoY Growth Revenue from Operations 447.8 314.7 1,630.0 1,243.7 Other Income 1.6 3.4 7.4 12.0 Total Income 449.4 318.1 41.3% 1,637.4 1,255.7 30.4% Cost of Material Consumed 296.7 198.0 1,052.8 814.1 Em

  13. Slide 13: Consolidated Balance Sheet

    Consolidated Balance Sheet Assets (₹ crore) Mar 2026 Mar 2025 Equity & Liabilities (₹ crore) Mar 2026 Mar 2025 Non - Current Assets 914.4 877.3 Total Equity 1,090.8 959.4 Property, plant and equipment 779.7 766.9 Share Capital 57.2 57.2 Right of use assets 43.7 45.5 Capital work-in-progress Other Eq

  14. Slide 14: Consolidated Cash Flow

    Consolidated Cash Flow Particulars (₹ crore) Mar 2026 Mar 2025 Net Profit Before Tax 188.3 171.0 Adjustments for: Non -Cash Items / Other Investment or Financial Items 57.6 27.4 Operating profit before working capital changes 245.9 198.4 Changes in working capital (103.1) (110.8) Cash generated from

  15. Slide 15: Key Strengths

    Key Strengths

  16. Slide 16: Building on Core Strengths, Unlocking Future Growth

    Building on Core Strengths, Unlocking Future Growth Extensive Product Offerings, Wider R&D Centric Reach, Stronger Organization Future Comprehensive Experienced Promoters Business Model and Board of Directors Relentless Expansion of Consistent Financial Manufacturing Capabilities: Performance Fuel f

  17. Slide 17: Relentless Expansion of Manufacturing Capabilities (1/3)

    Relentless Expansion of Manufacturing Capabilities: Fuel for Sustained Growth (1/3) Our manufacturing Capabilities Jammu Plant Dehradun & Taloja Plant Baddi Plant Expansion through New Greenfield Project Expansion through Inorganic 2025 onwards Acquisition Building blocks for growth 2024 Tablets Cap

  18. Slide 18: Capacity Expansion in Jammu (2/3)

    Capacity Expansion in Jammu (2/3) Eligible for following benefits via Central Government's 'New Central Sector Scheme ₹ 480+ crore GST-linked incentive totaling to 300% of investment made in Capital Interest Subvention of 6% per Total Capital Investment eligible plant and machinery annum on loan aga

  19. Slide 19: Growth led by Capacity Expansion (3/3)

    Growth led by Capacity Expansion (3/3) Baddi Plant Dehradun & Taloja Plant Jammu Plant 10% - 15% 10% - 15% 10%-15% 40%-50% 70%-75% 70% - 75% 70% - 80% 55% - 60% 60% - 70% 5% - 10% FY26 Un-utilized Capacity Optimum Utilization FY26 Un-utilized Capacity Optimum Utilization FY26 Ramp up in Further Opti

  20. Slide 20: Comprehensive Business Model

    Comprehensive Business Model CDMO Services and Products 4,200 + Products • Preferred partner for companies seeking to efficiently deliver high-quality, affordable medicines to market. • Consistently deliver high-quality solutions at scale, while maintaining the flexibility to tailor offerings to the

  21. Slide 21: Extensive Product Offerings, Wider Reach, Stronger Future

    Extensive Product Offerings, Wider Reach, Stronger Future FY21 FY26 Number of Products 1,000 + 4,200 + 4x Ongoing development of various formulations will drive continued growth in product offerings Focus on consistently adding new clients, Number of Customers 119 350+ 3x with sustained efforts to e

  22. Slide 22: R&D Focused Organisation

    R&D Focused Organisation 60+ R&D Laboratory Scientist & Engineers Baddi, Himachal Pradesh Robust Research and Development • Dedicated R&D facility and pilot equipment located in Baddi, Himachal Pradesh, recognized by the DSIR for its in-house R&D work • State-of-the-art facility equipped with a comp

  23. Slide 23: Experienced Promoters and Board of Directors

    Experienced Promoters and Board of Directors Mr. Manoj Kumar Lohariwala Mr. Vinay Lohariwala Mr. Jayant Vasudeo Rao Mr. Archit Aggarwal Chairman and Whole-Time Director Managing Director Whole-Time Director Non-Executive Non-Independent Director Mr. Sudhir Kumar Bassi Ms. Priyanka Dixit Sibal Mr. Ma

  24. Slide 24: Consistent Financial Performance

    Consistent Financial Performance Revenue from Operations EBITDA (₹ crore) PAT (₹ crore) (₹ crore) 12.4% 13.3% 15.4% 15.9% 15.4% 8.0% 7.3% 8.7% 10.3% 8.6% Margin 1,630 +19% 250 1,244 +26% 1,081 198 +22% 141 926 167 128 801 123 94 99 64 68 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY

  25. Slide 25: Historical Financial Performance

    Historical Financial Performance

  26. Slide 26: Consolidated Profit & Loss Statement

    Consolidated Profit & Loss Statement Profit and Loss (₹ crore) FY26 FY25 FY24 FY23 FY22 Revenue from Operations 1,630.0 1,243.7 1,081.3 926.4 800.5 Other Income 7.4 12.0 12.5 9.2 2.9 Total Revenue 1,637.4 1,255.7 1,093.8 935.6 803.4 Cost of Materials Consumed 1,052.8 814.1 728.3 691.6 617.9 Employee

  27. Slide 27: Consolidated Balance Sheet

    Consolidated Balance Sheet Assets (₹ crore) FY26 FY25 FY24 FY23 FY22 Equity & Liabilities (₹ crore) FY26 FY25 FY24 FY23 FY22 Non - Current Assets 914.4 877.3 741.1 261.9 196.4 Total Equity 1,090.8 959.4 830.9 276.5 208.6 Property, plant and equipment 779.7 766.9 291.6 150.1 156.6 Share Capital 57.2

  28. Slide 28: Consolidated Cash Flow

    Consolidated Cash Flow Particulars (₹ crore) FY26 FY25 FY24 FY23 FY22 Net Profit Before Tax 188.3 171.0 129.5 91.8 85.7 Adjustments for: Non -Cash Items / Other Investment or Financial Items 57.6 27.4 37.2 25.9 15.3 Operating profit before working capital changes 245.9 198.4 166.7 117.7 101.0 Change

  29. Slide 29: Thank You!

    Thank You! Innova Captab Limited : Investor Relations Advisor : http://www.sgapl.net/images/sgapl_logo.jpg Strategic Growth Advisors Pvt. Ltd. Innova Captab Ltd. CIN - U74140MH2010PTC204285 CIN – L24246MH2005PLC150371 Ms. Shaily Patwa / Mr. Shrikant Sangani Mr. Lokesh Bhasin Email – shaily.p@sgapl.n

Innova Captab — FY2026 Earnings Presentation on 6ix